Abbott Point Of Care Inc. recalls i-STAT CG8+ cartridge. List Number: 03P88-25. 510(k) numbers: K894914
Reason for recall
Lack of a 510(k) premarket clearance for the i-STAT CG8+, EG7+ and EG6+ cartridges to reflect updated sample type for potassium and ionized calcium and measurement ranges for pH and PO2.
Affected product
Check your device
Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.
i-STAT CG8+ cartridge. List Number: 03P88-25. 510(k) numbers: K894914, K940918, K223710, K230275, K230285, K230300
Lot / code information
List Number: 03P88-25. All lot numbers.
What the firm is doing
Abbott notified consignees via email and letter on about 08/21/2025. Consignees were instructed to download, review and implement the updated i-STAT CG8+, EG7+ and EG6+ cartridge Instructions for Use (IFU), discontinue use of i-STAT CG8+, EG7+ and EG6+ cartridges for testing of capillary whole blood samples for potassium and ionized calcium, and use venous or arterial whole blood or an alternate method for testing capillary potassium and ionized calcium. Update the pH and PO2 reportable ranges on the i-STAT 1 analyzers running i-STAT CG8+, EG7+ or EG6+ cartridges. As this feature is not customizable through the i STAT 1 handheld keypad, please see the i STAT DE Quick Reference Guide - Customizing Reportable Ranges (ART 770547-00 Revision A) for more information. To use the Custom Reportable Range feature, you must have the i-STAT 1 handheld and i STAT DE version 2.3 or higher. Changes to the reportable range may require a change to the Laboratory Information System (LIS) interface. Additionally, consignees were requested to confirm receipt and understanding of this communication by responding to the business reply card included with the letter. If consignees have forwarded any i-STAT CG8+, EG7+ or EG6+ cartridges to another facility, they were requested to notify them.
DistributionShow detailsHide
US Nationwide distribution.
Use of the product may cause temporary or medically reversible adverse health consequences.
Sources & references
- FDA enforcement recordOfficial FDA database entry for Z-2583-2025
- FDA device classification · CHLOfficial FDA classification for this device type
- CFR regulation · 21 CFR 862.1120The federal regulation governing this device
- FDA recall announcementSearch FDA.gov for the official press announcement
- Find Abbott Point Of Care Inc.Search for the manufacturer's official notice
- News coverageRecent reporting on this recall and manufacturer
- openFDA data recordThe raw JSON record this page is built from
Source: U.S. FDA openFDA device enforcement reports. This summary is informational and may lag or differ from the official record. Always verify against the FDA before acting.
Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.
More Class II recalls
Zimmer Surgical Inc recalls Brand Name: Sterile Tourniquet Hoses Product Name: A.T.S¿ 4000 TS Tourniquet Systems S…
Potential sterility breach in sealing area of sterile pouch. If used, issue may result in moderate localized infection. If discovered prior to use, may result in clinically insignificant extension of surgery to find anot…
- Pneumatic Tourniquet
- Under Investigation by firm
Zimmer Surgical Inc recalls Brand Name: Sterile Tourniquet Hoses Product Name: A.T.S¿ 4000 TS Tourniquet Systems D…
Potential sterility breach in sealing area of sterile pouch. If used, issue may result in moderate localized infection. If discovered prior to use, may result in clinically insignificant extension of surgery to find anot…
- Pneumatic Tourniquet
- Under Investigation by firm
W L Gore & Associates, Inc. recalls GORE¿ TAG¿ Thoracic Branch Endoprosthesis Side Branch Component Catalog Numbers (by Re…
Due to catheter separation
- Aortic Aneurysm Treatment Endovascular Graft System
- Under Investigation by firm
